The prospects for a human malaria vaccine

James F. Young, George Poste

Research output: Contribution to journalArticle

Abstract

Traditional methods of controlling malaria with insecticides and parasiticides have been inadequate. The use of hybridoma and recombinant DNA technologies to study the malaria parasite has permitted the identification of several antigens which may elicit protective immune responses. Clincial trials have begun to evaluate the merits of these molecules as vaccine candidates. It is hoped that their large scale production in genetically engineered hosts will result in the development of an effective vaccine.

Original languageEnglish (US)
Pages (from-to)63-68
Number of pages6
JournalTrends in Biotechnology
Volume6
Issue number3
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Malaria Vaccines
Vaccines
Malaria
Antiparasitic Agents
Genetic engineering
Insecticides
Recombinant DNA
Hybridomas
Antigens
Parasites
Technology
Molecules

ASJC Scopus subject areas

  • Bioengineering

Cite this

The prospects for a human malaria vaccine. / Young, James F.; Poste, George.

In: Trends in Biotechnology, Vol. 6, No. 3, 1988, p. 63-68.

Research output: Contribution to journalArticle

Young, James F. ; Poste, George. / The prospects for a human malaria vaccine. In: Trends in Biotechnology. 1988 ; Vol. 6, No. 3. pp. 63-68.
@article{627ad1373f1948a7aefc49bd8cd059d3,
title = "The prospects for a human malaria vaccine",
abstract = "Traditional methods of controlling malaria with insecticides and parasiticides have been inadequate. The use of hybridoma and recombinant DNA technologies to study the malaria parasite has permitted the identification of several antigens which may elicit protective immune responses. Clincial trials have begun to evaluate the merits of these molecules as vaccine candidates. It is hoped that their large scale production in genetically engineered hosts will result in the development of an effective vaccine.",
author = "Young, {James F.} and George Poste",
year = "1988",
doi = "10.1016/0167-7799(88)90093-5",
language = "English (US)",
volume = "6",
pages = "63--68",
journal = "Trends in Biotechnology",
issn = "0167-7799",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - The prospects for a human malaria vaccine

AU - Young, James F.

AU - Poste, George

PY - 1988

Y1 - 1988

N2 - Traditional methods of controlling malaria with insecticides and parasiticides have been inadequate. The use of hybridoma and recombinant DNA technologies to study the malaria parasite has permitted the identification of several antigens which may elicit protective immune responses. Clincial trials have begun to evaluate the merits of these molecules as vaccine candidates. It is hoped that their large scale production in genetically engineered hosts will result in the development of an effective vaccine.

AB - Traditional methods of controlling malaria with insecticides and parasiticides have been inadequate. The use of hybridoma and recombinant DNA technologies to study the malaria parasite has permitted the identification of several antigens which may elicit protective immune responses. Clincial trials have begun to evaluate the merits of these molecules as vaccine candidates. It is hoped that their large scale production in genetically engineered hosts will result in the development of an effective vaccine.

UR - http://www.scopus.com/inward/record.url?scp=17144471801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144471801&partnerID=8YFLogxK

U2 - 10.1016/0167-7799(88)90093-5

DO - 10.1016/0167-7799(88)90093-5

M3 - Article

AN - SCOPUS:17144471801

VL - 6

SP - 63

EP - 68

JO - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 3

ER -